Treatment uptake among notified cases of hepatitis C virus infection in Norway, 1990 to 2022: a registry-based study to monitor progress towards elimination.

Autor: Whittaker R; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway., Midgard H; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway., Dalgard O; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway., Kløvstad H; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Nov; Vol. 29 (46).

Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs.

Autor: Midgard, H.^1,2 (AUTHOR) havardmi@gmail.com, Finbråten, A. K.^3,4 (AUTHOR), Malme, K. B.¹ (AUTHOR), Berg-Pedersen, R. M.⁵ (AUTHOR), Tanum, L.^6,7 (AUTHOR), Olsen, I. C.⁸ (AUTHOR), Bjørnestad, R.⁹ (AUTHOR), Dalgard, O.^1,10 (AUTHOR)

Publikováno v: Trials. 6/15/2020, Vol. 21 Issue 1, p1-17. 17p. 3 Diagrams, 1 Chart.

Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial.

Autor: Malme KB; Department of Infectious Diseases, Akershus University Hospital, 1478 Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, 0371 Oslo, Norway., Stene-Johansen K; Department of Virology, Norwegian Institute of Public Health, 0304 Oslo, Norway., Klundby I; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Backe Ø; Agency for Social and Welfare Services, 0182 Oslo, Norway., Foshaug T; Agency for Social and Welfare Services, 0182 Oslo, Norway., Greve MH; Foundation of Franciscan Aid, Nurses on Wheels, 0651 Oslo, Norway., Pihl CM; Department of Medicine, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway., Finbråten AK; Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Dalgard O; Department of Infectious Diseases, Akershus University Hospital, 1478 Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, 0371 Oslo, Norway., Midgard H; Department of Gastroenterology, Oslo University Hospital, 0424 Oslo, Norway.

Publikováno v: Viruses [Viruses] 2024 May 27; Vol. 16 (6). Date of Electronic Publication: 2024 May 27.

Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial.

Autor: Midgard H; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway., Malme KB; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Pihl CM; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.; Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway., Berg-Pedersen RM; Department of Addiction Medicine, Oslo University Hospital, Oslo, Norway., Tanum L; Department for Research and Development in Mental Health, Akershus University Hospital, Lørenskog, Norway.; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway., Klundby I; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Haug A; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway., Tveter I; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway., Bjørnestad R; ProLAR Nett, Søgne, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Finbråten AK; Department of Medicine, Lovisenberg Diaconal Hospital, Oslo, Norway.; Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway., Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Mar 20; Vol. 78 (3), pp. 582-590.

Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study.

Autor: Malme KB; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: krimal@ahus.no., Ulstein K; Agency for Social and Welfare Services, City of Oslo, Norway., Finbråten AK; Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway., Wüsthoff LEC; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway; Unit for Clinical Research on Addictions, Oslo University Hospital Health Trust, Oslo, Norway., Kielland KB; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumundal, Norway., Hauge J; Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumundal, Norway., Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Norway., Midgard H; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2023 Jun; Vol. 116, pp. 104044. Date of Electronic Publication: 2023 May 05.